Search results for "diet"

showing 10 items of 4602 documents

Acceptability of partially dealcoholized wines - Measuring the impact of sensory and information cues on overall liking in real-life settings

2009

International audience; In this study, the effect of partial alcohol reduction in wine on consumer expectation and overall liking was investigated in real-life settings (by a Home-Use-Test). By varying the wine in the bottle and by manipulating the information on the label, it was possible to assess the relative impact of sensory properties and information cues on overall liking. Standard Chardonnay and Syrah wines were partially dealcoholized from about 13.5% to about 9.5%. After bottling, these dealcoholized wines were presented once with information about real alcohol content (9.5%) and once with false information about alcohol content (13.5%). A third bottle with standard wine inside wa…

business.product_categoryINFORMATION030309 nutrition & dieteticsSEGMENTATIONSensory system03 medical and health sciencesBottling line0404 agricultural biotechnology[SDV.IDA]Life Sciences [q-bio]/Food engineeringBottleIn real lifeEXPECTATIONSWine0303 health sciencesREAL-LIFE SETTINGSNutrition and DieteticsALCOHOL-REDUCED WINEdigestive oral and skin physiologyfood and beveragesAdvertising04 agricultural and veterinary sciences[SDV.IDA] Life Sciences [q-bio]/Food engineering040401 food sciencePreferenceLIKINGWine tastingPsychologybusinessSocial psychologyAlcohol reductionFood Science
researchProduct

Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet

2015

Background: the ketogenic diet (KD) has become a widely used nutritional approach for weight loss. Some of the KD’s positive effects on metabolism and cardiovascular risk factors are similar to those seen after n-3 polyunsaturated fatty acids (ω-3) supplementation. We hypothesized that a ketogenic Mediterranean diet with phytoextracts combined with ω-3 supplementation may have increased positive effects on cardiovascular risk factors and inflammation. Methods: We analyzed 34 male overweight subjects

cardiovascular risk factorsBlood GlucoseMaleMediterranean dietinflammatory cytokinesmedicine.medical_treatmentN-3 polyunsaturated fatty acidPharmaceutical ScienceOverweightDiet Mediterraneanchemistry.chemical_compoundRisk FactorsWeight lossDrug DiscoveryInsulinlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)Adipositychemistry.chemical_classificationCardiovascular risk factors; Inflammatory cytokines; Ketogenic diet; N-3 polyunsaturated fatty acids; Omega-3; Weight loss; Drug Discovery3003 Pharmaceutical ScienceMiddle Agedn-3 polyunsaturated fatty acidsketogenic dietCardiovascular DiseasesCytokinesomega-3medicine.symptomDiet KetogenicPolyunsaturated fatty acidAdultmedicine.medical_specialtyInflammatory cytokineBiologyCardiovascular risk factorWeight loArticleInternal medicineFatty Acids Omega-3Weight LossmedicineHumansTriglyceridesAgedAdiponectinPlant ExtractsCholesterolDrug Discovery3003 Pharmaceutical Science<i>n</i>-3 polyunsaturated fatty acidsCholesterol LDLOverweightEndocrinologylcsh:Biology (General)chemistryDietary SupplementsUric acidKetogenic dietMarine Drugs
researchProduct

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology …

2019

Aims The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods Patients (&lt;80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active &lt;30 min 5…

cardiovascular risk factorsMaleCardiac & Cardiovascular SystemsHeart diseaseEpidemiologymedicine.medical_treatmentHealth StatusEUROASPIRE ; cardiovascular risk factors ; guidelines ; lifestyle ; secondary preventionRisk Reduction Behavior*HSM CARRisk FactorsSecondary PreventionARTERY-DISEASEMyocardial infarctionEUROASPIREguidelinesDiet / adverse effectsRegistriesCardiovascular Diseases / physiopathology1102 Cardiorespiratory Medicine and HaematologyHydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*Smoking / epidemiologySmokingHealthy Lifestyle*Middle AgedPREVALENCEEuropeCardiovascular Diseases / diagnosisTreatment OutcomeCardiovascular DiseasesCardiovascular Agents / therapeutic use*LDL Cholesterol LipoproteinsFemaleEurope / epidemiologyCardiology and Cardiovascular MedicineLife Sciences & Biomedicinesecondary preventionmedicine.medical_specialtylifestyleSmoking / adverse effectsCardiovascular risk factorsHEART-DISEASERisk AssessmentLOW-INCOME COUNTRIESLife Style*Cardiovascular Diseases / prevention & control*Cardiovascular preventionmedicineJournal ArticleHumansHealthy Lifestyleddc:610Risk factorLife StyleAgedCardiovascular Diseases / epidemiologyScience & TechnologyTask forcebusiness.industryCardiovascular AgentsSMOKING-CESSATIONProtective Factorsmedicine.diseaseDietEUROASPIRE Investigators*Cross-Sectional StudiesMYOCARDIAL-INFARCTIONCLINICAL-PRACTICEFamily medicineHealth Care SurveysCardiovascular System & CardiologySmoking cessationPatient ComplianceHydroxymethylglutaryl-CoA Reductase InhibitorsSedentary BehaviorbusinessRisk Reduction BehaviorTASK-FORCE
researchProduct

CCDC 667553: Experimental Crystal Structure Determination

2008

Related Article: J.Kavalirova, M.Korabik, P.Stachova, J.Moncol, R.Sillanpaa, T.Lis, D.Miklos, M.Melnik, J.Mrozinski, D.Valigura|2008|Polyhedron|27|1333|doi:10.1016/j.poly.2007.12.030

catena-((mu~2~-NN-Diethylnicotinamide-NO)-tetrakis(mu~2~-2-nitrobenzoato-OO')-di-copper(ii))Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 789006: Experimental Crystal Structure Determination

2011

Related Article: M.Knorr, A.Pam, A.Khatyr, C.Strohmann, M.M.Kubicki, Y.Rousselin, S.M.Aly, D.Fortin, P.D.Harvey|2010|Inorg.Chem.|49|5834|doi:10.1021/ic901906h

catena-((mu~3~-Bromo)-bis(mu~2~-bromo)-bis(mu~2~-diethylsulfido)-diethylsulfido-tri-copper(i))Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 789009: Experimental Crystal Structure Determination

2011

Related Article: M.Knorr, A.Pam, A.Khatyr, C.Strohmann, M.M.Kubicki, Y.Rousselin, S.M.Aly, D.Fortin, P.D.Harvey|2010|Inorg.Chem.|49|5834|doi:10.1021/ic901906h

catena-((mu~3~-Bromo)-bis(mu~2~-bromo)-bis(mu~2~-diethylsulfido)-diethylsulfido-tri-copper(i))Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 789008: Experimental Crystal Structure Determination

2011

Related Article: M.Knorr, A.Pam, A.Khatyr, C.Strohmann, M.M.Kubicki, Y.Rousselin, S.M.Aly, D.Fortin, P.D.Harvey|2010|Inorg.Chem.|49|5834|doi:10.1021/ic901906h

catena-((mu~3~-Bromo)-bis(mu~2~-bromo)-bis(mu~2~-diethylsulfido)-diethylsulfido-tri-copper(i))Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 789007: Experimental Crystal Structure Determination

2011

Related Article: M.Knorr, A.Pam, A.Khatyr, C.Strohmann, M.M.Kubicki, Y.Rousselin, S.M.Aly, D.Fortin, P.D.Harvey|2010|Inorg.Chem.|49|5834|doi:10.1021/ic901906h

catena-((mu~3~-Bromo)-bis(mu~2~-bromo)-bis(mu~2~-diethylsulfido)-diethylsulfido-tri-copper(i))Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 748445: Experimental Crystal Structure Determination

2012

Related Article: D.Mal, R.Sen, E.Rentschler, K.Okamoto, Y.Miyashita, S.Koner|2012|Inorg.Chim.Acta|385|27|doi:10.1016/j.ica.2011.12.026

catena-(bis(mu~2~-dicyanamide)-(NN-diethylethane-12-diamine)-nickel(ii))Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1490105: Experimental Crystal Structure Determination

2016

Related Article: B. Abu Thaher, D. Schollmeyer, S. Laufer|2016|IUCrData|1|x161081|doi:10.1107/S2414314616010816

catena-[(mu-4-oxo-3-(pyridin-4-yl)-1-(246-trichlorophenyl)-45-dihydro-1H-pyrazolo[34-d]pyrimidin-6-olato)-(mu-methanol)-(methanol)-sodium methanol diethyl ether solvate]Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct